| 04/01/2020 |
APPOINTMENT / RESIGNATION OF COMPANY SECRETARY |
| 30/12/2020 |
RIGHTS ISSUE RESULTS & SHORTFALL NOTIFICATION |
| 07/12/2020 |
OFFER DOCUMENT ENTITLEMENT ISSUE |
| 12/10/2020 |
CEO appointment |
| 12/10/2020 |
Private Placement and Market update |
| 28/07/2020 |
FLU & COVID SYMPTOMS MONITORING LAUNCHED, SALES IN JULY |
| 28/07/2020 |
Appendix 4C: Quarterly Report 30 June 2020 |
| 31/10/2018 |
Seng Vital – The smart vaporizer system for medical cannabis |
| 21/03/2018 |
New Patient Self-Management System Launched |
| 28/02/2018 |
Preliminary Final Report |
| 31/01/2018 |
Appendix 4C – quarterly |
| 01/11/2017 |
Lifespot Health restructures its Business and Board |
| 31/10/2017 |
Appendix 4C – quarterly |
| 07/09/2017 |
Lifespot Signs Global Agreement With Beurer |
| 31/08/2017 |
Half Yearly Report and Accounts |
| 31/07/2017 |
Appendix 4C – quarterly |
| 28/07/2017 |
Digital Health Consortium Formed To Target $3.5B Market |
| 18/05/2017 |
Business & Operational Update |
| 01/05/2017 |
LSH enters $50Bn Global Medicinal Cannabis market |
| 28/04/2017 |
Appendix 4C – quarterly |
| 04/04/2017 |
Update on Medicinal Cannabis opportunities |
| 28/03/2017 |
Exploring opportunities in Medicinal Cannabis |
| 08/03/2017 |
Lifespot Health wins major contract & strategic b2b partner |
| 01/03/2017 |
Preliminary Final Report |
| 03/02/2017 |
Lifespot Health to enter coagulation home monitoring market |
| 16/01/2017 |
Market Update |
| 10/01/2017 |
ASX Market Release – Admission to the Official List |
